7,607 Shares in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Bought by Stifel Financial Corp

Stifel Financial Corp bought a new position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 7,607 shares of the company’s stock, valued at approximately $337,000.

A number of other large investors have also recently added to or reduced their stakes in XPH. BNP Paribas Financial Markets raised its position in SPDR S&P Pharmaceuticals ETF by 208.6% in the 3rd quarter. BNP Paribas Financial Markets now owns 149,419 shares of the company’s stock valued at $6,628,000 after buying an additional 101,000 shares during the last quarter. First Citizens Bank & Trust Co. grew its stake in shares of SPDR S&P Pharmaceuticals ETF by 9.5% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 72,053 shares of the company’s stock worth $3,196,000 after acquiring an additional 6,227 shares in the last quarter. AlphaMark Advisors LLC raised its holdings in shares of SPDR S&P Pharmaceuticals ETF by 5.9% in the third quarter. AlphaMark Advisors LLC now owns 6,225 shares of the company’s stock valued at $276,000 after purchasing an additional 348 shares during the last quarter. Rockport Wealth LLC bought a new stake in shares of SPDR S&P Pharmaceuticals ETF in the second quarter worth $1,813,000. Finally, Angeles Wealth Management LLC acquired a new position in SPDR S&P Pharmaceuticals ETF during the second quarter worth $40,000.

SPDR S&P Pharmaceuticals ETF Trading Down 1.2 %

Shares of XPH stock opened at $43.49 on Friday. The firm’s fifty day moving average price is $45.65 and its two-hundred day moving average price is $43.77. The firm has a market capitalization of $210.93 million, a P/E ratio of 14.39 and a beta of 0.87. SPDR S&P Pharmaceuticals ETF has a 1 year low of $38.88 and a 1 year high of $48.76.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.